High Mobility Group Protein B1 Market Analysis & Forecast 2024-2030

High Mobility Group Protein B1 Market by Product Type (Dociparstat Sodium, RBM-005, EV-007156) by Application / End /User (Autoimmune Disorders, Cerebral Infarction, Chemotherapy Effects, Cancer) Industry Analysis, Volume, Share, Growth,Challenges,Key Players, Trends, Regions and Forecast 2024-2030, Regional Outlook ( North America, Europe, Asia-Pacific, Middle-East, Africa)

Report Code: PSMR- 104          Category: Biotechnology          Region :  Global         Report Format :                  

 Request Free Sample


    ×

     Table of Contents

    High Mobility Group Protein B1 (HMGB1) also known as High mobility group box 1 or SBP-1 is protein encoded by HMGB1 gene. HMGB1 is secreted by immune cells such as monocytes, macrophages, and dendritic cells through leaderless secretory pathway. Activated macrophages and monocytes secrete HMGB1. High Mobility Group Box protein 1 (HMGB1) is a non-alkaline (non-histonic) DNA-binding protein, it is normally localized in the nucleus as part of the chromatin. High Mobility Group Protein B1 is member of chromatin proteins which also includes, HMG1, HMG 2, HMG 14, and HMG 17.  


    HMGB1 with its high positive charge binds to DNA leads to oxidation, hyperacetylation and posttranslational modifications. HMGB1 is responsible for Stabilization of the nucleosomal structure and regulation of gene transcription in chromatin. It is released by necrotic cells hence act as chaperone to shuttle nuclei acids into the endosomal compartment of APCs. Nucleic acid sensors like TLR9 trigger due to High Mobility Group Protein B1 (HMGB1) . HMGB1 also has the ability to bind LPS, at the level of lipid A, possibly because of its high positive electric charge. It can chaperone to the CD14-TLR4 MD2 complex, increasing the response of macrophages to the LPS.  


    High Mobility Group Protein B1 (HMGB1) has its importance in:

    • Cellular processes such as inflammation, cell differentiation and tumor cell migration.
    • Clearance of apoptotic cells, such as in autoimmune diseases
    • Splicing results in multiple transcript variants that encode the same protein.
    • Antibodies that neutralize HMGB1 can be used to protects against damage and tissue injury during arthritis, lupus erythematosus, colitis, sepsis, endotoxemia, and ischemia.
    • thermodynamic stability with electrostatic interactions between the acidic tail and the HMG box.
    • The C-terminal acidic tail of HMGB1 helps in the maintenance of protein stability.

    High Mobility Group Protein B1 Market : Key Player

    • Affibody AB
    • Cantex Pharmaceuticals Inc
    • Dicerna Pharmaceuticals Inc
    • Evec Inc
    • Ribomic Inc

    High Mobility Group Protein B1 Market: End User / Application Type

    • Autoimmune Disorders
    • Cerebral Infarction
    • Chemotherapy Effects
    • Cancer Treatment

    High Mobility Group Protein B1 Market : Product Type

    • Dociparstat Sodium
    • RBM-005
    • EV-007156

    Global High Mobility Group Protein B1 Market: Regional Analysis

    • North America
      • U.S.A
      • Canada
    • Europe
      • France
      • Germany
      • Spain
      • UK
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • South East Asia
    • Latin America
      • Brazil
    • Middle East and Africa

    High Mobility Group Protein B1 Market Report delivers a comprehensive analysis of the following parameters :

    • Market Forecast for
    • Market growth drivers
    • Challenges and Opportunities
    • Emerging and Current market trends
    • Market player Capacity, Production, Revenue (Value)
    • Supply (Production), Consumption, Export, Import analysis
    • End-user/application Analysis

    Global High Mobility Group Protein B1 Market Report delivers a comprehensive analysis of the following parameters:

    • Market Forecast for 2024-2030
    • Market growth drivers
    • Challenges and Opportunities
    • Emerging and Current market trends
    • Market player Capacity, Production, Revenue (Value)
    • Supply (Production), Consumption, Export, Import analysis
    • End user/application Analysis

    Report Coverage

    Parameters Details

    Base Year

    2023

    Historical Data

    2018-2023

    Forecast Data

    2024-2030

    Regional Scope

    North America, Europe, Asian Pacific, Latin America, Middle East and Africa, and ROW

    Frequently Asked Questions (FAQ)


    High Mobility Group Protein B1 Market report considers 2021 as the base year.




    High Mobility Group Protein B1 Market report considers data for period 2016 to 2021 as the historical data to predict market forecast between 2022 to 2029.




    Yes, report is inclusive in-detailed analysis of key players in High Mobility Group Protein B1 Market




    High Mobility Group Protein B1 Market Study is broadly divided into North America, Europe, Asian Pacific, Latin America, Middle East and Africa, and ROW. Also these regions are further analysed as per various countries




    High Mobility Group Protein B1 Market Report includes Market Segmentation, Regional outlook, Application Analysis, Competitive analysis, Supply-Demand Analysis, Pricing insight.




    Yes, the report includes COVID 19 impact on the market.



    Purchase Options

      Online Access $2450

      PDF Access $3550

      PDF + Dashboard $4050
        Access

    Inquire Before Buying

    Please fill below details:

      ×
      Free Customization

      We are committed to offering 100 % free customization while purchasing.



        Access the FREE Sample

        Receive a detailed insight into the High Mobility Group Protein B1 Market research study with our FREE sample report delivered straight to your email. The report covers major market factors such as Revenue, Forecast, Top companies insight, Regional analysis, Market trends & more.

         Request Free Sample


          ×